Efficient Cancer Therapy with a Nanobody-Based Conjugate
Virna Cortez‐Retamozo(Vrije Universiteit Brussel), Hilde Revets, Serge Muyldermans(Vrije Universiteit Brussel), Peter D. Senter(North Carolina Central University), Ullrich Wernery(Central Veterinary Research Laboratory), Patrick De Baetselier(Vrije Universiteit Brussel), Natalija Backmann(Vrije Universiteit Brussel)
Cited by 372
Related Papers
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
|Clinical Cancer Research|2004|1.2k
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
|Nature Biotechnology|2003|1.2k
Arming antibodies: prospects and challenges for immunoconjugates
|Nature Biotechnology|2005|1k
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
|Blood|2003|918
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772